Stay updated on Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The update involves formatting and layout adjustments to the study details page and does not modify core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:50:29.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    2%
    Check dated 2025-10-06T04:24:29.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Update includes adding revision v3.1.0 and removing the Melanoma/Cutaneous Malignant category, replacing the older v3.0.2 marker.
    Difference
    0.1%
    Check dated 2025-09-28T23:41:02.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Version bumped to v3.0.2 and Back to Top removed; overall, no significant changes to core content or critical data.
    Difference
    0.1%
    Check dated 2025-09-14T09:54:00.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T07:45:31.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of publications related to a specific clinical study, while several previous location details and medical terms have been removed.
    Difference
    5%
    Check dated 2025-08-31T00:55:14.000Z thumbnail image

Stay in the know with updates to Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.